| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2010-01-266668 |
| P8608 | Fatcat ID | release_zn63vh4k2bclzf4h77f2b76z7m |
| P698 | PubMed publication ID | 20339090 |
| P5875 | ResearchGate publication ID | 42589210 |
| P50 | author | Thierry Defrance | Q62669243 |
| Olivier Thaunat | Q64918274 | ||
| P2093 | author name string | Emmanuel Morelon | |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 515-521 | |
| P577 | publication date | 2010-03-25 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis | |
| P478 | volume | 116 |
| Q35674857 | A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood |
| Q59799931 | Are we aiming to miss in translational autoimmunity treatments? |
| Q54980047 | B Cell Modulation Strategies in Autoimmune Diseases: New Concepts. |
| Q61165112 | B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses |
| Q42330142 | BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset |
| Q89621173 | Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses |
| Q27013040 | Cell therapy to induce allograft tolerance: time to switch to plan B? |
| Q53229165 | Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys. |
| Q38266375 | Clinical implications of basic science discoveries: janus resurrected--two faces of B cell and plasma cell biology |
| Q38731333 | Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant. |
| Q37943547 | Essential role for B cells in transplantation tolerance. |
| Q33352583 | Humoral immunity in chronic allograft rejection: puzzle pieces come together |
| Q36036340 | Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. |
| Q35612362 | Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses |
| Q50910869 | Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. |
| Q39084586 | Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs. |
| Q43097558 | Overcoming bortezomib resistance in human B cells by anti-CD20/rituximab-mediated complement-dependent cytotoxicity and epoxyketone-based irreversible proteasome inhibitors |
| Q37644833 | PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas |
| Q33986006 | Primary B-cell deficiencies reveal a link between human IL-17-producing CD4 T-cell homeostasis and B-cell differentiation |
| Q38028778 | Pushing the limits of targeted therapy in chronic myeloid leukaemia. |
| Q47893977 | TIM-4 Identifies IFN-γ-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection |
| Q33987668 | The role of B cells in transplantation and immunopathic diseases |
| Q37970443 | Update on the role of rituximab in kidney diseases and transplant |
Search more.